Paper6439773
Estrogenic treatment does not modify the TSH and PRL responses to domperidone and TRH in patients with tumoral hyperprolactinemia.
Ghigo E and 5 others. J Endocrinol Invest, 1984. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Estrogenic treatment does not modify the TSH and PRL responses to domperidone and TRH in patients with tumoral hyperprolactinemia. Papers, record 6439773. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6439773
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Estrogenic treatment does not modify the TSH and PRL responses to domperidone and TRH in patients with tumoral hyperprolactinemia.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ethinyl Estradiol | Major topic |
| Pituitary Neoplasms | Major topic |
| Prolactin | Major topic |
| Thyrotropin | Major topic |
| Adult | |
| Domperidone | |
| Female | |
| Follicular Phase | |
| Humans | |
| Thyrotropin-Releasing Hormone |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,205,100 | Lack of effect of steroids on thyrotropin-releasing hormone (TRH) mediated thyrotropin (TSH) release in man. | Neuroendocrinology | 1973 | https://conductscience.org/library/papers/4205100 | PubMed |
| 2 | 6,299,038 | Basal and TRH stimulated serum levels of TSH in patients with hyperprolactinaemia and in subjects on oestrogen treatment. | Acta Endocrinol (Copenh) | 1983 | https://conductscience.org/library/papers/6299038 | PubMed |
| 3 | 7,193,686 | Predictors of the outcome of transsphenoidal surgery for prolactin-secreting pituitary adenomas. | J Clin Endocrinol Metab | 1981 | https://conductscience.org/library/papers/7193686 | PubMed |
| 4 | 6,790,201 | Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function. | Clin Endocrinol (Oxf) | 1981 | https://conductscience.org/library/papers/6790201 | PubMed |
| 5 | 70,641 | Evidence for dopaminergic control of thyrotrophin secretion in man. | Lancet | 1977 | https://conductscience.org/library/papers/70641 | PubMed |
| 6 | 569,030 | Increased thyrotrophin secretion induced by sulpiride in man. | Clin Endocrinol (Oxf) | 1978 | https://conductscience.org/library/papers/569030 | PubMed |
| 7 | 6,851,194 | Reciprocal pattern of the TSH and PRL responses to dopamine receptor blockade in women with physiological or pathological hyperprolactinaemia. | Clin Endocrinol (Oxf) | 1983 | https://conductscience.org/library/papers/6851194 | PubMed |
| 8 | 6,113,354 | Heterogeneity of prolactin responses to oestradiol benzoate in women with prolactinomas. | Lancet | 1981 | https://conductscience.org/library/papers/6113354 | PubMed |
| 9 | 403,039 | Effect of stilboesterol therapy on thyrotrophin-releasing hormone (TRH) responsiveness in males. | Clin Endocrinol (Oxf) | 1977 | https://conductscience.org/library/papers/403039 | PubMed |
| 10 | 4,202,502 | Enhanced plasma thyrotrophin response to thyrotrophin-releasing hormone following oestradiol administration in man. | Clin Endocrinol (Oxf) | 1973 | https://conductscience.org/library/papers/4202502 | PubMed |
| 11 | 810,492 | Dopamine infusion acutely inhibits the TSH and prolactin response to TRH. | J Clin Endocrinol Metab | 1975 | https://conductscience.org/library/papers/810492 | PubMed |
| 12 | 4,206,493 | Growth hormone, thyrotropin, and prolactin responses to thyrotropin-releasing hormone following diethylstilbestrol pretreatment. | J Clin Endocrinol Metab | 1973 | https://conductscience.org/library/papers/4206493 | PubMed |
| 13 | 231,066 | Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin. | J Endocrinol Invest | 1979 | https://conductscience.org/library/papers/231066 | PubMed |
| 14 | 908,151 | Increased prolactin and thyrotrophin secretion following oral metoclopramide: dose-response relationships. | Clin Endocrinol (Oxf) | 1977 | https://conductscience.org/library/papers/908151 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 2,685,096 | Hyperprolactinemia: neuroendocrine and diagnostic aspects. | J Endocrinol Invest | 1989 | https://conductscience.org/library/papers/2685096 |
Source PubMed
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| PRL | 5,617 | PubTator's text mining | https://conductscience.org/library/genes/5617 | NCBI Gene |
| TRH | 7,200 | PubTator's text mining | https://conductscience.org/library/genes/7200 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6439773
GET https://conductscience.org/api/papers/v1/6439773/authors